ELVN
Enliven Therapeutics, Inc. Common Stock
$54.81
1.59%
+0.86
Notify me if price changes either direction
Buy ELVN stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
3.9B
Enterprise value
2.8B
Trailing PE
-29.918032786885
Forward PE
-23.204302
PEG Ratio
0.89754098360656
Enterprise to EBITDA
-24
Price to book MRQ
7.245501
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-03-31
EBITDA
-115585000
Diluted EPS TTM
-1.64
Total Cash (MRQ)
452.4M
Current ratio (MRQ)
40.318
Operating Cash Flow (TTM)
-65465000
ELVN trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
August 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
